A Peptide-Major Histocompatibility Complex II Chimera Favors Survival of Pancreatic β-Ιslets Grafted in Type 1 Diabetic Mice

The peptide-MHC II chimera approach is an efficient and specific therapeutic approach to suppress anti-islet T cell responses and provides a long survival of...